Block Randomized Implementation of a Decision-Making Algorithm for Renal Replacement Therapy Initiation in AKI Compared with Standard Care on AKI-Related Outcomes
Yvelynne P. Kelly(Tallaght University Hospital), Mallika L. Mendu(Brigham and Women's Hospital), David E. Leaf(Brigham and Women's Hospital), Peter G. Czarnecki(Beth Israel Deaconess Medical Center), Sushrut S. Waikar(Metabolism and Renal Physiology), Ernest I. Mandel(Harvard University), Emily Robinson(Brigham and Women's Hospital), Gearoid M. McMahon(Brigham and Women's Hospital), David M. Charytan(NYU Langone Health), Salman Ahmed(Brigham and Women's Hospital)
Cited by 0
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2011|928
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
|The Lancet Diabetes & Endocrinology|2019|870
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716